FOXP3 expression in esophageal squamous cell carcinoma : Implications for cetuximab sensitivity and therapeutic strategies
CONCLUSION: High FOXP3 expression promotes the proliferation and migration of ESCC cells, while negatively affecting their sensitivity to cetuximab-targeted therapy. Consequently, targeting FOXP3 shows potential therapeutic implications for enhancing the effectiveness of cetuximab treatment in ESCC patients.PMID:37874348 | DOI:10.1007/s00508-023-02291-4
Source: Wiener Klinische Wochenschrift - Category: General Medicine Authors: Shenghong Wu Yu Wang Zhijun Xiao Jinfeng Zhang Zhonghui He Ming Ye Source Type: research
More News: Cancer & Oncology | Carcinoma | Erbitux | Esophagus Cancer | General Medicine | Genetics | Skin Cancer | Squamous Cell Carcinoma